Found: 18
Select item for more details and to access through your institution.
Use of Transient Transfection for cGMP Manufacturing of eOD-GT8 60mer, a Self-Assembling Nanoparticle Germline-Targeting HIV-1 Vaccine Candidate.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 6, p. 742, doi. 10.3390/pharmaceutics16060742
- By:
- Publication type:
- Article
mRNA-LNP prime boost evolves precursors toward VRC01-like broadly neutralizing antibodies in preclinical humanized mouse models.
- Published in:
- Science Immunology, 2024, v. 9, n. 95, p. 1, doi. 10.1126/sciimmunol.adn0622
- By:
- Publication type:
- Article
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00811-5
- By:
- Publication type:
- Article
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 697, p. 1, doi. 10.1126/scitranslmed.adf3309
- By:
- Publication type:
- Article
Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-020-00223-1
- By:
- Publication type:
- Article
In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure‐Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive Immunity.
- Published in:
- Advanced Science, 2020, v. 7, n. 8, p. 1, doi. 10.1002/advs.201902802
- By:
- Publication type:
- Article
Nanoparticle Vaccines: In Vivo Assembly of Nanoparticles Achieved through Synergy of Structure‐Based Protein Engineering and Synthetic DNA Generates Enhanced Adaptive Immunity (Adv. Sci. 8/2020).
- Published in:
- Advanced Science, 2020, v. 7, n. 8, p. 1, doi. 10.1002/advs.202070044
- By:
- Publication type:
- Article
Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-34853-2
- By:
- Publication type:
- Article
Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-06121-4
- By:
- Publication type:
- Article
The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 448, p. 1, doi. 10.1126/scitranslmed.aat0381
- By:
- Publication type:
- Article
Glycoengineering HIV-1 Env creates ‘supercharged’ and ‘hybrid’ glycans to increase neutralizing antibody potency, breadth and saturation.
- Published in:
- PLoS Pathogens, 2018, v. 14, n. 5, p. 1, doi. 10.1371/journal.ppat.1007024
- By:
- Publication type:
- Article
Global site-specific N-glycosylation analysis of HIV envelope glycoprotein.
- Published in:
- Nature Communications, 2017, v. 8, n. 3, p. 14954, doi. 10.1038/ncomms14954
- By:
- Publication type:
- Article
Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies.
- Published in:
- Nature Communications, 2015, v. 6, n. 6, p. 7479, doi. 10.1038/ncomms8479
- By:
- Publication type:
- Article
Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 5, p. 1, doi. 10.1371/journal.ppat.1004932
- By:
- Publication type:
- Article
Comprehensive Sieve Analysis of Breakthrough HIV-1 Sequences in the RV144 Vaccine Efficacy Trial.
- Published in:
- PLoS Computational Biology, 2015, v. 11, n. 2, p. 1, doi. 10.1371/journal.pcbi.1003973
- By:
- Publication type:
- Article
Promiscuous Glycan Site Recognition by Antibodies to the High-Mannose Patch of gp120 Broadens Neutralization of HIV.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 236, p. 1, doi. 10.1126/scitranslmed.3008104
- By:
- Publication type:
- Article
An HIV-1 Envelope Glycoprotein Trimer with an Embedded IL-21 Domain Activates Human B Cells.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0067309
- By:
- Publication type:
- Article
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.
- Published in:
- Nature, 2012, v. 490, n. 7420, p. 417, doi. 10.1038/nature11519
- By:
- Publication type:
- Article